Can rapamycin and metformin fight aging and extend lifespan? Evidence, risks, and Taiwan regulations for two 'longevity drugs'.
Rapamycin (sirolimus) and metformin have recently been called 'anti-aging wonder drugs' in longevity circles, but this is external marketing and expectation, not fact: both are prescription drugs, and their use for anti-aging or lifespan extension is 'unproven' and not an approved indication. Rapamycin extends lifespan in mice, but mouse results do not equal human benefit—current randomized trials in healthy individuals (PEARL) did not meet primary endpoints; metformin's anti-aging evidence is even more controversial, with some studies suggesting it may blunt the benefits of exercise. Below is a neutral summary of evidence, risks, and Taiwan regulations; both are investigational, carry risks, require physician evaluation, and should not be self-administered. Refer to the latest TFDA announcements; this page is for informational purposes only, not medical advice.
What are these two drugs? Why are they called 'longevity drugs'?
Each originally has approved uses; they gained the 'longevity drug' label due to animal and mechanistic studies discussed in longevity circles:
- Rapamycin (sirolimus): an mTOR inhibitor, approved for organ transplant anti-rejection (immunosuppression) and lymphangioleiomyomatosis (LAM), not an anti-aging drug
- Metformin: first-line oral drug for type 2 diabetes, not an anti-aging drug
- The terms 'anti-aging wonder drug/longevity pill' are external claims and expectations; both are used off-label for anti-aging, with unproven effects
Rapamycin: extends lifespan in mice, but human evidence remains very limited
Distinguish between 'animal experiments' and 'human confirmation':
- The NIA's Interventions Testing Program (ITP) has repeatedly found that rapamycin extends lifespan in mice across multiple labs, even when given late in life—this is notable animal evidence
- But mouse lifespan extension does not equal human benefit: the randomized controlled trial PEARL (114 people, weekly dosing for 1 year) in healthy humans did not meet its primary endpoint; visceral fat was not significantly different from placebo
- Currently, no evidence shows rapamycin extends human lifespan or healthspan; many positive online claims come from commercial entities selling the drug, so conflicts of interest should be noted
Metformin: anti-aging evidence is actually controversial
Metformin is often portrayed as an anti-aging panacea, but the evidence is more inconsistent than expected:
- The TAME trial (led by AFAR and Nir Barzilai) is a planned/ongoing large trial designed to 'test' whether metformin can delay age-related diseases—this means it has not yet been proven, not that it has been proven.
- In NIA ITP mouse studies, metformin alone did not extend lifespan; no randomized controlled trials exist for extending lifespan in healthy, non-diabetic individuals.
- Some studies (e.g., Konopka et al., 2019) even suggest that metformin may blunt mitochondrial adaptations and physical improvements from exercise training in older adults—contrary to the 'anti-aging' impression, worth balanced consideration.
Risks and side effects cannot be ignored
Both are prescription drugs with risks requiring physician monitoring:
- Rapamycin: immunosuppression, increased infection risk, common oral ulcers, delayed wound healing, elevated blood glucose and lipids, and cytopenias; the so-called 'longevity' intermittent dosing regimen is unproven and experimental.
- Metformin: common gastrointestinal discomfort, long-term use may cause vitamin B12 deficiency, rare but serious lactic acidosis (risk increases with renal impairment, infection, hypoxia), contraindicated in severe renal impairment.
- These require physician evaluation and monitoring based on individual conditions, not self-administration based on online information.
Taiwan regulations and neutral perspective
In Taiwan, the use and advertising of these drugs are regulated, and anti-aging is not an approved indication:
- Rapamycin and metformin are both prescription drugs in Taiwan, approved by the TFDA for their respective indications (transplant anti-rejection/diabetes); use for anti-aging is off-label, requiring a physician's prescription, and should not be self-purchased from pharmacies.
- Medical regulations restrict exaggerated or false medical advertising; claims like 'longevity pills' should be viewed conservatively.
- Summary: No drug has been proven or approved to delay human aging; rapamycin and metformin remain in the research stage. Whether they are suitable or if there are other health considerations should be discussed with a qualified physician, and the latest TFDA announcements should be followed. This page provides neutral information, not medical advice.
FAQ
Can rapamycin and metformin really fight aging and extend lifespan?
Currently unproven, and neither is approved for anti-aging use. Rapamycin extends lifespan in mice, but the randomized trial (PEARL) in healthy humans did not meet its primary endpoint. Evidence for metformin's anti-aging effects is controversial, and no randomized controlled trial exists for lifespan extension in non-diabetic healthy individuals. Both are prescription drugs, still in research phase, and anti-aging use is off-label. This page provides neutral information, not medical advice.
Mouse studies show rapamycin extends lifespan; does the same apply to humans?
Direct extrapolation is not possible. The NIA's ITP program has repeatedly shown rapamycin extends lifespan in mice across multiple labs, which is a notable animal evidence. However, animal lifespan extension does not equate to human benefit. In fact, the PEARL trial in healthy humans did not meet its primary endpoint, and there is currently no evidence that it extends human lifespan or healthspan. Some positive online claims come from entities selling the drug, so conflicts of interest should be noted.
Is metformin safe enough to be used for anti-aging?
It is a familiar drug when used for diabetes, but its anti-aging use is unproven and evidence is controversial: the TAME trial is still in the testing phase (meaning it has not yet been proven), metformin alone did not extend lifespan in mice, and some studies suggest it may blunt the physical benefits of exercise. Additionally, long-term use carries risks such as B12 deficiency and rare lactic acidosis. Self-administration for anti-aging is not recommended.
Can I buy and take these drugs myself for 'maintenance'?
Not recommended. Both are prescription drugs that require evaluation and monitoring by a physician based on individual conditions. Purchasing them from pharmacies for anti-aging purposes poses health risks (e.g., immunosuppression from rapamycin, lactic acidosis from metformin) and does not align with proper medical practice and medication safety. Anti-aging use is off-label and unproven; if considering, consult a qualified physician.
What are the side effects of rapamycin?
Rapamycin suppresses immunity, increasing infection risk. Common side effects include oral ulcers, delayed wound healing, elevated blood glucose and lipids, and low blood cell counts. The safety of long-term or high-dose use in healthy individuals has not been established. The so-called 'longevity' intermittent dosing regimen is unproven and experimental. Use should be evaluated by a physician; this page does not recommend self-use.
So, is there any drug proven to slow aging?
As of now, no drug has been proven or approved to slow human aging. Rapamycin, metformin, and other discussed 'longevity drugs' are still in the research phase—promising in animals or mechanisms, but human evidence is insufficient. Instead of pursuing unproven drugs, regular exercise, balanced diet, sleep, and chronic disease management remain evidence-based foundations for healthy aging. Consult a physician if in doubt.
This page is a neutral compilation of information for reference only, not medical advice, and does not constitute any diagnostic commitment.